On November 24 and 25, the Bioengineering and Medtech against cancer short course will take place in digital format. The course has the aim of showing the advances and new approaches to fight it, thanks to nanomedicine, biophysics, mechanobiology, biotechnology and ICT. In addition to the conferences, there will be an innovation track with pitches from companies and projects and matchmaking opportunities with KOL and investors.
This short course is part of ToHealth program, an EIT Health activity. The course is organized by Medicen Paris and the Institute for Bioengineering of Catalonia (IBEC), with the collaboration of Biocat, “la Caixa” Foundation and Meditecnologia, under the framework of B·Debate.
The language of the event will be English.